A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Participants

In brief

A Study assessing the drug levels and drug effects of variable doses of BMS-986322 in Healthy Participants compared to a placebo. The study also assesses how BMS-986322 affects the body with food and its acidity levels.

Key facts

Study ID

NCT04175925

Run by

Bristol-Myers Squibb

People needed

171

Starts

2019-11-15

Expected to finish

2021-07-13

Last updated by the study team

2022-05-31

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy Participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
• Body mass index (BMI) of 18.0 kg/m\^2 to 32.0 kg/m\^2, inclusive, and body weight ≥ 50 kg, at screening
• Women and men must agree to follow methods of contraception.

You may not qualify if…

• Any significant acute or chronic medical illness
• History of recent infection
• History of allergy to BMS-986322 or other compounds
• Other protocol-defined inclusion/exclusion criteria could apply.

Where it is running

• ICON (LPRA) - Lenexa — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.